Last update 18 Sep 2026
Nuance Pharma

Nuance Pharma

Private Company|
10-50
|
www.nuancepharma.com

Overview

Tags

Respiratory Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Immune System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
PDE3 x PDE41

Related

1
Drugs associated with Nuance Pharma
Ensifentrine
Target
PDE3 x PDE4
Mechanism
PDE3 inhibitors [+1]
Active Org.
Verona Pharma, Inc. [+7]
Originator Org.
Verona Pharma Ltd.Verona Pharma Ltd.
Active Indication
Pulmonary Disease, Chronic Obstructive [+3]
Inactive Indication
Asthma chronic [+4]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
United States
First Approval Date26 Jun 2024
100 Clinical Results associated with Nuance Pharma
Login to view more data
0 Patents (Medical) associated with Nuance Pharma
Login to view more data
100 Deals associated with Nuance Pharma
Login to view more data
100 Translational Medicine associated with Nuance Pharma
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 04 Oct 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
NDA/BLA
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ensifentrine
 ( PDE3 x PDE4 )		Pulmonary Disease, Chronic Obstructive
More
NDA/BLA
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free